Skip To The Main Content
Mark D. Pflug
 

Mark D. Pflug

Partner
 
425 Lexington Avenue
New York, NY 10017 
 
Email:
Fax: +1-212-455-2502

Mark Pflug advises on a wide variety of mergers and acquisitions transactions, including strategic business combinations, leveraged buyouts and other private equity sponsor-led transactions, minority investments in public and private companies, joint ventures, spin-offs and split-offs, divestitures, and other corporate matters. Mark has particular and significant experience in the healthcare, technology, media and industrials sectors, as well as cross-border transactions in numerous European and Asian jurisdictions. Mark regularly represents both corporate clients, including CSL, CBRE, Alibaba and others, and private equity sponsors, both large-cap and middle-market, including KKR, Blackstone, Snow Phipps (now TruArc Partners) and Lexington Partners. Mark also regularly works for many of the portfolio companies of his private equity clients. Mark has been recognized by IFLR1000 as a “Highly Regarded” attorney for his work in M&A and private equity. Mark currently is based in New York, and previously spent eight years resident in the Firm’s London office and practiced as a registered foreign lawyer in the Firm’s Hong Kong office.

Read Full Biography...

Work Highlights
  • KKR in numerous transactions, including the $1.4 billion acquisition of PharMerica and in PharMerica’s strategic combination with BrightSpring Health Services; the acquisition of Heartland Dental; the $2.0 billion sale of Aricent; the acquisition of PetVet Care Centers; the $5.5 billion sale of Capsugel; the acquisition of Epicor Software; the sale of Ipreo Holdings; the $21.2 billion acquisition of Alliance Boots (UK) and its subsequent business combination with Walgreen Co.; the $7.2 billion acquisition of Samson Resources; the $5.8 billion sale of Oriental Brewery (Korea); and acquisitions of or investments in Qingdao Haier Co., Ltd. (China), Gland Pharma Limited (India), Weststar Aviation Services Sdn. Bhd. (Malaysia), PT Tiga Pilar Sejahtera Food Tbk. (Indonesia), Alliance Tires Group B.V. (India), Fotolia Holdings, Inc., and BMG Rights Management GmbH (Germany)
  • CBRE in its announced acquisition a 60% interest in and strategic partnership with Turner & Townsend and its investment in Industrious
  • CBRE Acquisition Holdings (a SPAC sponsored by CBRE) in its announced business combination with Altus Power
  • CSL in its acquisition of Vitaeris, its exclusive license of a novel late-stage gene therapy candidate for hemophilia B patients from uniQure, and the formation of the CoVIg-19 Plasma Alliance
  • Gardner Denver Holdings, Inc. in its merger with Ingersoll-Rand plc’s Industrial segment
  • Blackstone in multiple transactions, including its investment in JDA Software (now Blue Yonder), its investment in PEM Manufacturing, its sale of Emcure Pharmaceuticals (India) and its investment in Agile Electric (India)
  • Lexington Partners in multiple secondary transactions, including TPG Asia V and VI, Metalmark and interests in Asian-based portfolio companies owned by Warburg Pincus Private Equity XI L.P.
  • Snow Phipps in multiple transactions, including its acquisition of Prototek, its acquisition of BlackHawk Industrial Distribution, its acquisition and subsequent disposition of Winchester Electronics Corporation and other engagements
  • Alibaba Group in several acquisitions and investments
  • Global Medical Response (formerly Air Medical Group), in its acquisition of Air Medical Resources Group and other matters
  • PRA Health Sciences in a technology investment
  • Toshiba Medical Systems in its acquisition of Vital Images
Education
  • Columbia Law School, 1995 J.D.
    Harlan Fiske Stone Scholar
  • Rochester Institute of Technology, 1992 B.S.
    magna cum laude
Admissions
  • New York 1996

Mark Pflug advises on a wide variety of mergers and acquisitions transactions, including strategic business combinations, leveraged buyouts and other private equity sponsor-led transactions, minority investments in public and private companies, joint ventures, spin-offs and split-offs, divestitures, and other corporate matters. Mark has particular and significant experience in the healthcare, technology, media and industrials sectors, as well as cross-border transactions in numerous European and Asian jurisdictions.

Mark regularly represents both corporate clients, including CSL, CBRE, Alibaba and others, and private equity sponsors, both large-cap and middle-market, including KKR, Blackstone, Snow Phipps (now TruArc Partners) and Lexington Partners. Mark also regularly works for many of the portfolio companies of his private equity clients. 

Mark has been recognized by IFLR1000 as a “Highly Regarded” attorney for his work in M&A and private equity. Mark currently is based in New York, and previously spent eight years resident in the Firm’s London office and practiced as a registered foreign lawyer in the Firm’s Hong Kong office. Mark co-chairs the Firm’s Insurance Committee and serves on the Firm’s Business Development Committee.

Work Highlights

  • KKR in numerous transactions, including the $1.4 billion acquisition of PharMerica and in PharMerica’s strategic combination with BrightSpring Health Services; the acquisition of Heartland Dental; the $2.0 billion sale of Aricent; the acquisition of PetVet Care Centers; the $5.5 billion sale of Capsugel; the acquisition of Epicor Software; the sale of Ipreo Holdings; the $21.2 billion acquisition of Alliance Boots (UK) and its subsequent business combination with Walgreen Co.; the $7.2 billion acquisition of Samson Resources; the $5.8 billion sale of Oriental Brewery (Korea); and acquisitions of or investments in Qingdao Haier Co., Ltd. (China), Gland Pharma Limited (India), Weststar Aviation Services Sdn. Bhd. (Malaysia), PT Tiga Pilar Sejahtera Food Tbk. (Indonesia), Alliance Tires Group B.V. (India), Fotolia Holdings, Inc., and BMG Rights Management GmbH (Germany)
  • CBRE in its announced acquisition a 60% interest in and strategic partnership with Turner & Townsend and its investment in Industrious
  • CBRE Acquisition Holdings (a SPAC sponsored by CBRE) in its announced business combination with Altus Power
  • CSL in its acquisition of Vitaeris, its exclusive license of a novel late-stage gene therapy candidate for hemophilia B patients from uniQure, and the formation of the CoVIg-19 Plasma Alliance
  • Gardner Denver Holdings, Inc. in its merger with Ingersoll-Rand plc’s Industrial segment
  • Blackstone in multiple transactions, including its investment in JDA Software (now Blue Yonder), its investment in PEM Manufacturing, its sale of Emcure Pharmaceuticals (India) and its investment in Agile Electric (India)
  • Lexington Partners in multiple secondary transactions, including TPG Asia V and VI, Metalmark and interests in Asian-based portfolio companies owned by Warburg Pincus Private Equity XI L.P.
  • Snow Phipps in multiple transactions, including its acquisition of Prototek, its acquisition of BlackHawk Industrial Distribution, its acquisition and subsequent disposition of Winchester Electronics Corporation and other engagements
  • Alibaba Group in several acquisitions and investments
  • Global Medical Response (formerly Air Medical Group), in its acquisition of Air Medical Resources Group and other matters
  • PRA Health Sciences in a technology investment
  • Toshiba Medical Systems in its acquisition of Vital Images

From 2000 to 2008, Mark was resident in the Firm’s London office, during which time he worked on many European cross-border transactions, including the acquisitions of U.N Ro-Ro Isletmeleri AS (Turkey, 2007); Alliance Boots plc (UK, 2007); ProSiebenSat.1 AG (Germany, 2007); Tarkett SA (France, 2007); NXP BV (Netherlands, 2006); PagesJaunes Groupe SA (France, 2006); BIS Cleanaway Ltd (Australia, 2006); FL Selenia SpA (Italy, 2005); SBS Broadcasting Sarl (Luxembourg, 2005); Maxeda (f/k/a Vendex KBB) (Netherlands, 2004); MTU Aero Engines GmbH (Germany, 2003); and Legrand (France, 2002). Several of these transactions were the largest transactions of their kind at the time of announcement. The Alliance Boots acquisition today continues to rank as the largest-ever buyout in Europe and was the first relating to an FTSE 100 company.  

Mark received his J.D. from Columbia Law School in 1995, where he was a Harlan Fiske Stone Scholar. He received his B.S., high honors, from Rochester Institute of Technology in 1992.

News & Events

    Publications